Dimitrios S Goumenos
Overview
Explore the profile of Dimitrios S Goumenos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chasapi S, Karagkouni E, Kalavrizioti D, Vamvakas S, Zompra A, Takis P, et al.
Metabolites
. 2022 Jun;
12(6).
PMID: 35736423
Chronic Kidney Disease (CKD) is considered as a major public health problem as it can lead to end-stage kidney failure, which requires replacement therapy. A prompt and accurate diagnosis, along...
12.
Papasotiriou M, Stangou M, Chlorogiannis D, Marinaki S, Xydakis D, Sampani E, et al.
Front Med (Lausanne)
. 2022 Mar;
9:778464.
PMID: 35242773
Background: Immunoglobulin A nephropathy (IgAN) is among the commonest glomerulonephritides in Greece and an important cause of end-stage kidney disease (ESKD) with an insidious chronic course. Thus, the recently published...
13.
Papasotiriou M, Ntrinias T, Savvidaki E, Papachristou E, Goumenos D
Transplant Proc
. 2021 Oct;
53(9):2775-2778.
PMID: 34602294
Dyslipidemia is common in kidney transplant recipients owing to the disturbance of lipid metabolism caused by chronic kidney disease and the effect of immunosuppression on lipid metabolism. Patients receiving treatment...
14.
Mpratsiakou A, Papasotiriou M, Ntrinias T, Tsiotsios K, Papachristou E, Goumenos D
Exp Clin Transplant
. 2021 May;
19(5):411-419.
PMID: 34053420
Objectives: The appearance of new onset diabetes is common after kidney transplant. Treatment options are limited because of renal function-related contraindications, interactions with immunosuppressive drugs, and side effects. We investigated...
15.
Pavlakou P, Papasotiriou M, Ntrinias T, Kourakli A, Bratsiakou A, Goumenos D, et al.
Front Med (Lausanne)
. 2021 Mar;
8:665475.
PMID: 33777986
Lupus nephritis in the context of Systemic Lupus Erythematosus (SLE) is characterized by an unpredicted course with remissions and flare-ups. Among others, it remains a significant cause of end-stage kidney...
16.
Favorable effects of peritoneal dialysis in patients with refractory heart failure and overhydration
Papasotiriou M, Liakopoulos V, Kehagias I, Vareta G, Ntrinias T, Papachristou E, et al.
Perit Dial Int
. 2020 Nov;
42(1):48-56.
PMID: 33250003
Background: Patients with refractory to optimal pharmacological treatment heart failure (HF) require frequent hospitalization. Peritoneal dialysis (PD) has been part of the management of such patients mainly for promoting ultrafiltration...
17.
Plytzanopoulou P, Papasotiriou M, Politis P, Parissis C, Paraskevopoulou P, Kehagias I, et al.
Int Urol Nephrol
. 2020 Sep;
52(11):2205-2212.
PMID: 32964341
Purpose: Cardiac valve calcification (CVC) is a significant risk factor for cardiovascular morbidity and mortality in patients with chronic kidney disease on maintenance hemodialysis. The aim of this study was...
18.
Ntrinias T, Papasotiriou M, Balta L, Kalavrizioti D, Vamvakas S, Papachristou E, et al.
Pril (Makedon Akad Nauk Umet Odd Med Nauki)
. 2020 Feb;
40(3):27-39.
PMID: 32109222
The traditional chronic kidney disease (CKD) biomarkers (eGFR based on serum creatinine, sex and age and albuminuria) cannot predict a patient's individual risk for developing progressive CKD. For this reason,...
19.
Pappas E, Mpournaka S, Katopodis P, Chardalias A, Tsakas S, Theodoros T, et al.
Pril (Makedon Akad Nauk Umet Odd Med Nauki)
. 2019 Oct;
40(2):25-32.
PMID: 31605588
Chronic Kidney Disease (CKD) is characterized by immune activation with development of chronic inflammation. However, immune deficiency also exists in CKD patients. The number and the activity of Natural Killer...
20.
Oikonomaki T, Papasotiriou M, Ntrinias T, Kalogeropoulou C, Zabakis P, Kalavrizioti D, et al.
Int Urol Nephrol
. 2019 Sep;
51(11):2037-2044.
PMID: 31529295
Purpose: Vascular calcification (VC) is an independent risk factor for cardiovascular disease in hemodialysis patients while Matrix GLA protein (MGP) is one of the most potent inhibitors of VC and...